Taffic Tablet

Description

 

Generic  Name:

Taffic Tablet contains Bictegravir, Emtricitabine, and Tenofovir Alafenamide, a combination used in modern antiretroviral therapy for HIV-1 infection. These medicines work together to lower viral load, support immune function, and improve treatment outcomes with convenient once-daily dosing.

 

Composition:

Each Taffic Tablet comprises:

• Bictegravir 50 mg: Works as an INSTI, blocking HIV integrase and stopping the virus from integrating into host DNA.
• Emtricitabine 200 mg: Works as an NRTI, interfering with reverse transcriptase and preventing viral DNA synthesis.
• Tenofovir Alafenamide 25 mg: Also an NRTI, helping reduce HIV replication by blocking viral DNA production.

 

Why This Combination is Effective:

The combination of one INSTI (Bictegravir) and two NRTIs (Emtricitabine + Tenofovir Alafenamide) provides a multi-targeted approach to block HIV-1 replication at different stages. This makes Taffic Tablet an effective once-daily antiretroviral therapy (ART) for reducing viral load, supporting immune function, and maintaining long-term viral suppression.

 

Indication:

Taffic is used for the treatment of HIV-1 infection in adults and adolescents. It is prescribed as a single-tablet regimen for patients who have no known resistance to integrase inhibitors, nucleoside reverse transcriptase inhibitors (NRTIs), or tenofovir.

 

Storage Instructions:

• Store at room temperature (25°C) in a dry place.
• Keep away from direct sunlight and moisture.
• Keep out of reach of children.

 

Uses of the Taffic Tablet:

• Taffic Tablet is used for the treatment of HIV-1 infection as part of once-daily antiretroviral therapy.
• It helps reduce the viral load in the blood, supporting better long-term HIV treatment outcomes.
• Taffic Tablet also helps maintain or improve CD4 cell count, which supports immune system function.
• By controlling HIV replication, it may help lower the risk of disease progression and related infections.
• When taken regularly as prescribed, Taffic Tablet supports effective and sustained viral suppression.

 

Taffic Tablet Price:

The Taffic Tablet price in India is around ₹2,600 for a pack, making it an accessible option for patients seeking reliable HIV-1 treatment. This once-daily antiretroviral medicine contains Bictegravir, Emtricitabine, and Tenofovir Alafenamide. Please note that prices may vary depending on pharmacy location and availability.

 

Benefits of the Taffic Tablet:

• Controls HIV Viral Load: Taffic Tablet helps suppress HIV replication and reduce the viral load, supporting effective HIV treatment.
• Supports Immunity: By helping maintain healthy CD4 cell count, it supports the immune system and overall HIV management.
• Once-Daily Convenience: A single-tablet, once-daily antiretroviral therapy that improves treatment adherence.
• Supports Long-Term HIV Control: Regular use of Taffic Tablet helps maintain viral suppression and improve treatment outcomes.

 

Common Side Effects of Taffic Tablet:

• Nausea
• Diarrhea
• Fatigue
• Headache
• Insomnia
• Dizziness

 

Serious Side Effects of Taffic Tablet:

• Liver toxicity (yellowing of skin/eyes, dark urine)
• Lactic acidosis (muscle pain, weakness, breathing difficulty)
• Severe allergic reactions (rash, swelling, difficulty breathing)
• Kidney problems (increased thirst, changes in urination)

 

How to Use the Taffic Tablet:

• Take one tablet daily at the same time each day.
• Can be taken with or without food.
• Swallow whole with water; do not chew or crush.
• Do not miss doses to maintain viral suppression.

 

How the Taffic Tablet Works:

• Taffic is a fixed-dose combination antiretroviral that contains:
• Bictegravir: An integrase strand transfer inhibitor (INSTI) that blocks viral replication.
• Emtricitabine & Tenofovir Alafenamide: Nucleoside reverse transcriptase inhibitors (NRTIs) that prevent HIV from copying itself.
• Together, these components help reduce HIV viral load and slow disease progression.

 

What If You Forget to Take the Taffic Tablet?

• Take the missed dose as soon as you remember.
• If it’s almost time for the next dose, skip the missed dose.
• Do not double the dose to compensate.

 

Best Practices for Adherence to Taffic Tablet:

• Take it at the same time every day: This helps maintain steady medicine levels for effective HIV treatment.
• Do not miss doses: Missing doses may reduce effectiveness and affect long-term viral suppression.
• Follow your doctor’s prescription: Take Taffic Tablet exactly as advised and do not stop treatment without medical guidance.
• Stay consistent with treatment: Regular daily use is important for controlling HIV-1 and supporting immune health.

 

Quick Tips:

• Take Taffic daily to ensure effective HIV suppression.
• Regular HIV viral load and CD4 tests are necessary to monitor treatment effectiveness.
• Do not share your medication with others.
• Inform your doctor if you have a history of liver or kidney disease.

 

Safety Advice:

Caution is advised when consuming alcohol with Taffic Tablet. Please consult your doctor for guidance.

 

Taffic Tablet is unsafe to use during pregnancy due to potential harm to the developing baby. It may only be prescribed in life-threatening situations where benefits outweigh the risks. Please consult your doctor.

 

There is insufficient information on the use of Taffic Tablet while breastfeeding. Please consult your doctor before use.

 

It is uncertain whether Taffic Tablet affects your ability to drive. Avoid driving if you experience drowsiness, dizziness, or reduced alertness.

 

Limited data is available on the safety of Taffic Tablet in patients with kidney disease. Dose adjustments may be necessary. Please consult your doctor.

 

Taffic Tablet should be used with caution in patients with liver disease. Dose adjustments may be required based on the severity of the condition. Please consult your doctor.

 

Manufacturer:

Taffic Tablet is manufactured by Hetero, a well-known pharmaceutical company recognized for producing high-quality antiretroviral medicines used in HIV-1 treatment. Hetero has a strong presence in the healthcare sector and is known for offering reliable therapies that support effective viral suppression and long-term HIV management.

 

FAQs:

Q: What is Taffic Tablet used for?

A: Taffic Tablet is used for the treatment of HIV-1 infection as part of antiretroviral therapy. It helps reduce the viral load in the blood and supports long-term HIV management when taken as prescribed.

 

Q: What is the composition of Taffic Tablet?

A: The Taffic tablet composition includes Bictegravir 50 mg, Emtricitabine 200 mg, and Tenofovir Alafenamide 25 mg. These three medicines work together to control HIV replication at different stages.

 

Q: Can Taffic Tablet cure HIV?

A: No, Taffic Tablet does not cure HIV-1 infection. It helps control the virus, reduce viral load, and improve treatment outcomes when used regularly as part of long-term HIV treatment.

 

Q: How should Taffic Tablet be taken?

A:Taffic Tablet is usually taken once daily, with or without food, exactly as prescribed by a doctor. It should be taken regularly to maintain effective HIV-1 treatment.

 

Q: Can Taffic Tablet be taken with other medicines?

A:Taffic Tablet may interact with certain other medicines, including some supplements, antibiotics, and antiviral drugs. Always inform your doctor about all medicines you are taking before starting treatment.

 

Q: Is Taffic Tablet safe during pregnancy or breastfeeding?

A:Pregnant or breastfeeding women should take Taffic Tablet only under medical supervision. A doctor will evaluate the benefits and possible risks before prescribing it.

 

Q: How long do I need to take Taffic Tablet?

A:Taffic Tablet is generally used as a long-term treatment for HIV-1 infection. Patients should continue the medicine exactly as prescribed and should not stop treatment without consulting a doctor.

 

Q: Can I stop taking Taffic Tablet if I feel better?

A:No, you should not stop Taffic Tablet without medical advice. Stopping treatment early may increase the risk of viral rebound, treatment failure, or drug resistance.

 

Related Lab Tests:

• HIV viral load test
• CD4 count
• Liver function test
• Kidney function test

 

Other Resources :

HIV.gov – Emtricitabine Patient Guide